Cited by 637Genomics, phytochemicals, and oxidative stressRedox biology and oxidative stressBioactive Compounds and Antitumor Agents

The DOI matches its Crossref record; 110 of the 114 references it cites were found in a registry or an index.

The Dual Roles of NRF2 in Cancer

Open access

Menegon, Silvia, Columbano, Amedeo, Giordano, Silvia·2016·Trends in Molecular Medicine

DOI 10.1016/j.molmed.2016.05.002

Open this paper in CoChat — free account Open PDF

Abstract

NRF2 has been traditionally considered as a tumor suppressor because its cytoprotective functions are deemed to be the main cellular defense mechanism against exogenous and endogenous insults, including xenobiotics and oxidative stress. However, several recent studies demonstrate that hyperactivation of the NRF2 pathway creates an environment that favors the survival of normal as well as malignant cells, protecting them against oxidative stress, chemotherapeutic agents, and radiotherapy. In a rapidly advancing field, this review summarizes some of the known mechanisms by which NRF2 can exert its oncogenic functions, and describes the current status of NRF2 inhibitors, providing a clear rationale for the consideration of NRF2 as a powerful putative therapeutic target in cancer treatment.

Integrity signals

Registry

Crossref · 10.1016/j.molmed.2016.05.002

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Untitled work
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D. L., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,161
The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1
Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y.-S., Ueno, I., Sakamoto, A., Tong, K. I., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2021 · Cited by 2,288
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277
Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Nrf2–Keap1 defines a physiologically important stress response mechanism
Motohashi, H., & Yamamoto, M. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.003 · Cited by 1,725 · cited 1×
“NRF2: Tumor Suppressor or Oncogene? The main function of the transcription factor NRF2 [also known as NFE2L2, nuclear factor (erythroid-derived-2)-like 2] is to activate the cellular antioxidant response by inducing the transcription of several genes to protect cells from the effects of exogenous and endogenous insult…”
Background
Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region
Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Benmaad, I., Caldéraro, J., Bioulac‐Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,522

Flagged first, then by citations

Show all 114 references

4 of the 114 references couldn’t be matched to a known paper.

Sorted by citations

ROS in cancer therapy: the bright side of the moon
Perillo, B., Di Donato, M., Pezone, A., Di Zazzo, E., Giovannelli, P., Galasso, G., Castoria, G., & Migliaccio, A. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0384-2 · Cited by 2,176
Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach
Glorieux, C., & Calderón, P. B. (2017) · Biological Chemistry · doi:10.1515/hsz-2017-0131 · Cited by 692
Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments
Zuo, L., Prather, E. R., Stetskiv, M., Garrison, D. E., Meade, J. R., Peace, T. I., & Zhou, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184472 · Cited by 560
The KEAP1–NRF2 System in Cancer
Taguchi, K., & Yamamoto, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00085 · Cited by 527
Interplay of oxidative stress, cellular communication and signaling pathways in cancer
Iqbal, M. J., Kabeer, A., Abbas, Z., Siddiqui, H. A., Călina, D. C., Sharifi‐Rad, J., & Cho, W. C. S. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01398-5 · Cited by 426
Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer
Koundouros, N., & Poulogiannis, G. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00160 · Cited by 425
Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer
Bae, T., Hallis, S. P., & Kwak, M. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01180-8 · Cited by 410
The Role of Nrf2 Activity in Cancer Development and Progression
Zimța, A., Cenariu, D., Irimie, A., Magdo, L., Nabavi, S. M., Atanasov, A. G., & Berindan‐Neagoe, I. (2019) · Cancers · doi:10.3390/cancers11111755 · Cited by 309
Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential
Kashyap, D., Garg, V. K., Tuli, H. S., Yerer, M. B., Sak, K., Sharma, A. K., Kumar, M., Aggarwal, V., & Sandhu, S. S. (2019) · Biomolecules · doi:10.3390/biom9050174 · Cited by 285
Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
Habault, J., & Poyet, J. (2019) · Molecules · doi:10.3390/molecules24050927 · Cited by 282
Cancer metabolism and mitochondria: Finding novel mechanisms to fight tumours
Missiroli, S., Perrone, M., Genovese, I., Pinton, P., & Giorgi, C. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102943 · Cited by 263
Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach
Nouri, Z., Fakhri, S., Nouri, K., Wallace, C. E., Farzaei, M. H., & Bishayee, A. (2020) · Cancers · doi:10.3390/cancers12082276 · Cited by 246
Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy
Shi, S., Chen, Y., Luo, Z., Nie, G., & Dai, Y. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01077-5 · Cited by 251
NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer
Zhang, K., Dong, C., Ma, K., Wu, X., Hao, H., & Jiang, S. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00124 · Cited by 222
Recent Advances of Natural Polyphenols Activators for Keap1‐Nrf2 Signaling Pathway
Zhou, Y., Jiang, Z., Lu, H., Xu, Z., Tong, R., Shi, J., & Jia, G. (2019) · Chemistry & Biodiversity · doi:10.1002/cbdv.201900400 · Cited by 220
Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment
Best, S. A., De Souza, D. P., Kersbergen, A., Policheni, A. N., Dayalan, S., Tull, D., Rathi, V., Gray, D. H., Ritchie, M. E., McConville, M. J., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.006 · Cited by 217
Nrf2: Redox and Metabolic Regulator of Stem Cell State and Function
Dai, X., Yan, X., Wintergerst, K. A., Cai, L., Keller, B. B., & Tan, Y. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.09.007 · Cited by 209
Dual role of Endoplasmic Reticulum Stress-Mediated Unfolded Protein Response Signaling Pathway in Carcinogenesis
Siwecka, N., Rozpędek‐Kamińska, W., Pytel, D., Wawrzynkiewicz, A., Dziki, A. J., Dziki, Ł. A., Diehl, J. A., & Majsterek, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184354 · Cited by 199
Nrf2 targeting by sulforaphane: A potential therapy for cancer treatment
Russo, M., Spagnuolo, C., Russo, G. L., Skalicka‐Woźniak, K., Daglia, M., Sobarzo‐Sánchez, E., Nabavi, S. F., & Nabavi, S. M. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1259983 · Cited by 199
Redox toxicology of environmental chemicals causing oxidative stress
Zheng, F., Gonçalves, F. M., Abiko, Y., Li, H., Kumagai, Y., & Aschner, M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101475 · Cited by 198
Emerging role of NRF2 in ROS-mediated tumor chemoresistance
Xue, D., Zhou, X., & Qiu, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110676 · Cited by 195
NRF2 Activation in Cancer: From DNA to Protein
Cloer, E. W., Goldfarb, D., Schrank, T. P., Weissman, B. E., & Major, M. B. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2723 · Cited by 182
Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance
Raghunath, A., Sundarraj, K., Arfuso, F., Sethi, G., & Perumal, E. (2018) · Cancers · doi:10.3390/cancers10120481 · Cited by 187
Potential Applications of NRF2 Inhibitors in Cancer Therapy
Panieri, E., & Saso, L. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8592348 · Cited by 189
Genetic alterations in hepatocellular carcinoma: An update
Niu, Z.-S., Niu, X.-J., & Wang, W. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i41.9069 · Cited by 193
Regulation of Nrf2 by phosphorylation: Consequences for biological function and therapeutic implications
Liu, T., Lv, Y., Zhao, J., You, Q., & Jiang, Z. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.034 · Cited by 177
The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase
Sanghvi, V. R., Leibold, J., Mina, M., Mohan, P., Berishaj, M., Li, Z., Miele, M. M., Lailler, N., Zhao, C., de Stanchina, E., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.031 · Cited by 155
Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers
Liang, X., Weng, J., You, Z., Wang, Y., Wen, J., Xia, Z., Huang, S., Luo, P., & Cheng, Q. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02375-x · Cited by 204
Potential Applications of NRF2 Modulators in Cancer Therapy
Panieri, E., Djordjević, A. B., Telkoparan‐Akillilar, P., Cevik, D., Kouretas, D., Veskoukis, A. S., Skaperda, Z., Tsatsakis, A. M., Wallace, D., Süzen, S., et al. (2020) · Antioxidants · doi:10.3390/antiox9030193 · Cited by 167
The Role of NRF2/KEAP1 Signaling Pathway in Cancer Metabolism
Song, M.-Y., Lee, D.-Y., Chun, K., & Kim, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094376 · Cited by 170
Dimethyl fumarate, a two‐edged drug: Current status and future directions
Saidu, N. E. B., Kavian, N., Leroy, K., Jacob, C., Nicco, C., Batteux, F., & Alexandre, J. (2019) · Medicinal Research Reviews · doi:10.1002/med.21567 · Cited by 166
Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic
Shah, F., Logsdon, D. P., Messmann, R. A., Fehrenbacher, J. C., Fishel, M. L., & Kelley, M. R. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0023-0 · Cited by 155
Disease Tolerance as an Inherent Component of Immunity
Martins, R., Carlos, A. R., Braza, F., Thompson, J. A., Bastos-Amador, P., Ramos, S., & Soares, M. P. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041739 · Cited by 151
Endoplasmic reticulum-mediated unfolded protein response and mitochondrial apoptosis in cancer
Bhat, T. A., Chaudhary, A. K., Kumar, S., O’Malley, J., Inigo, J. R., Kumar, R., Yadav, N., & Chandra, D. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.12.002 · Cited by 157
Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial
Pastorelli, D., Fabricio, A. S. C., Giovanis, P., D'Ippolito, S., Fiduccia, P., Soldà, C., Buda, A., Sperti, C., Bardini, R., Dalt, G. D., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.013 · Cited by 156
The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure
Galiè, M., Covi, V., Tabaracci, G., & Malatesta, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164009 · Cited by 177
Outcompeting cancer
Vishwakarma, M., & Piddini, E. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-019-0231-8 · Cited by 149
Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma
Kowalik, M. A., Columbano, A., & Perra, A. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00087 · Cited by 152
Self-citation
Controversy about pharmacological modulation of Nrf2 for cancer therapy
Milković, L., Žarković, N., & Saso, L. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.013 · Cited by 142
Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways
Almatroodi, S. A., Alsahli, M. A., & Rahmani, A. H. (2022) · Molecules · doi:10.3390/molecules27185889 · Cited by 152
Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
Telkoparan‐Akillilar, P., Panieri, E., Cevik, D., Süzen, S., & Saso, L. (2021) · Molecules · doi:10.3390/molecules26051417 · Cited by 148
Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma
Salam, R., Saliou, A., Bielle, F., Bertrand, M., Antoniewski, C., Carpentier, C., Alentorn, A., Capelle, L., Sanson, M., Huillard, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36124-9 · Cited by 132
Cinnamaldehyde Prevents Endothelial Dysfunction Induced by High Glucose by Activating Nrf2
Wang, F., Pu, C., Zhou, P., Wang, P., Liang, D., Wang, Q., Hu, Y., Li, B., & Hao, X. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000374074 · Cited by 130
Multifaceted Roles of Glutathione and Glutathione-Based Systems in Carcinogenesis and Anticancer Drug Resistance
Hatem, E., Banna, N. E., & Huang, M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7134 · Cited by 127
Potential Mechanisms of Action of Dietary Phytochemicals for Cancer Prevention by Targeting Cellular Signaling Transduction Pathways
Chen, H., & Liu, R. H. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b04975 · Cited by 127
Integrative clinical and molecular characterization of translocation renal cell carcinoma
Bakouny, Z., Sadagopan, A., Ravi, P. K., Metaferia, N. Y., Li, J., AbuHammad, S., Tang, S., Denize, T., Garner, E. R., Gao, X. Y., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110190 · Cited by 123
NRF2 regulates the sensitivity of human NSCLC cells to cystine deprivation-induced ferroptosis via FOCAD-FAK signaling pathway
Liu, P., Wu, D., Duan, J., Xiao, H., Zhou, Y., Zhao, L., & Feng, Y. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101702 · Cited by 125
New perspectives on the therapeutic potential of quercetin in non-communicable diseases: Targeting Nrf2 to counteract oxidative stress and inflammation
Zhang, L., Xu, L.-Y., Tang, F., Liu, D., Zhao, X.-L., Zhang, J.-N., Xia, J., Wu, J.-J., Yang, Y., Peng, C. Y., et al. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.12.020 · Cited by 130
NAC, NAC, Knockin’ on Heaven's door: Interpreting the mechanism of action of N-acetylcysteine in tumor and immune cells
Kalyanaraman, B. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102497 · Cited by 128
Role of NRF2 in Lung Cancer
Sánchez-Ortega, M., Carrera, A. C., & Garrido, A. (2021) · Cells · doi:10.3390/cells10081879 · Cited by 130
Oxidative Stress and Cancer Therapy: Controlling Cancer Cells Using Reactive Oxygen Species
Ju, S., Singh, M. K., Han, S., Ranbhise, J. S., Ha, J., Choe, W., Yoon, K., Yeo, S. G., Kim, S. S., & Kang, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212387 · Cited by 133
Sorting out the Value of Cruciferous Sprouts as Sources of Bioactive Compounds for Nutrition and Health
Abellán, Á., Domínguez‐Perles, R., Moreno, D. A., & García‐Viguera, C. (2019) · Nutrients · doi:10.3390/nu11020429 · Cited by 122
Identification of a functional antioxidant response element at the HIF1A locus
Lacher, S. E., Levings, D. C., Freeman, S., & Slattery, M. G. (2018) · Redox Biology · doi:10.1016/j.redox.2018.08.014 · Cited by 123
Apigenin: A natural bioactive flavone-type molecule with promising therapeutic function
Kashyap, D., Sharma, A. K., Tuli, H. S., Sak, K., Garg, V. K., Buttar, H. S., Setzer, W. N., & Sethi, G. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.07.037 · Cited by 120
Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells
Lisek, K., Campaner, E., Ciani, Y., Walerych, D., & Sal, G. D. (2018) · Oncotarget · doi:10.18632/oncotarget.24974 · Cited by 119
A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer
Choi, E.-J., Jung, B.-J., Lee, S.-H., Yoo, H.-S., Shin, E.-A., Ko, H., Chang, S., Kim, S.-Y., & Jeon, S.-M. (2017) · Oncogene · doi:10.1038/onc.2017.153 · Cited by 115
Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling
Koeberle, S. C., Kipp, A. P., Stuppner, H., & Koeberle, A. (2023) · Medicinal Research Reviews · doi:10.1002/med.21933 · Cited by 117
Understanding the Role of Free Radicals and Antioxidant Enzymes in Human Diseases
Chaudhary, N., Roy, Z., Bansal, R., & Siddiqui, L. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201024666221121160822 · Cited by 114
p62/ SQSTM 1—Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer
Taniguchi, K., Yamachika, S., He, F., & Karin, M. (2016) · FEBS Letters · doi:10.1002/1873-3468.12301 · Cited by 117
The Central Role of Amino Acids in Cancer Redox Homeostasis: Vulnerability Points of the Cancer Redox Code
Vučetić, M., Cormerais, Y., Parks, S. K., & Pouysségur, J. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00319 · Cited by 121
Are polyphenol antioxidants at the root of medicinal plant anti-cancer success?
Oyenihi, A., & Smith, C. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.09.037 · Cited by 107
The dual role of curcumin and ferulic acid in counteracting chemoresistance and cisplatin-induced ototoxicity
Paciello, F., Fetoni, A. R., Mezzogori, D., Rolesi, R., Pino, A. D., Paludetti, G., Grassi, C., & Troiani, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-57965-0 · Cited by 110
Resveratrol induced reactive oxygen species and endoplasmic reticulum stress‑mediated apoptosis, and cell cycle arrest in the A375SM malignant melanoma cell line
Heo, J., Kim, S., Hwang, K., Kang, J., & Choi, K. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3732 · Cited by 107
Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate
Satoh, T., & Lipton, S. A. (2017) · F1000Research · doi:10.12688/f1000research.12111.1 · Cited by 106
Methylglyoxal-derived stress: An emerging biological factor involved in the onset and progression of cancer
Bellahcène, A., Nokin, M.-J., Castronovo, V., & Schalkwijk, C. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.010 · Cited by 98
ABCF2 , an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells
Bao, L., Wu, J., Dodson, M. B., de la Vega, E. M. R., Ning, Y., Zhang, Z., Yao, M., Zhang, D. D., Xu, C., & Yi, X. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22615 · Cited by 101
Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer
Hampton, M. B., Vick, K. A., Skoko, J., & Neumann, C. A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7422 · Cited by 103
Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review
Sova, M., & Saso, L. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s172612 · Cited by 104
Chrysin suppresses proliferation, migration, and invasion in glioblastoma cell lines via mediating the ERK/Nrf2 signaling pathway
Wang, J., Wang, H., Sun, K., Wang, X., Pan, H., Zhu, J., Ji, X., & Li, X. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s160020 · Cited by 99
Activating de novo mutations in NFE2L2 encoding NRF2 cause a multisystem disorder
Huppke, P., Weißbach, S., Church, J. A., Schnur, R. E., Krusen, M., Dreha‐Kulaczewski, S. F., Kühn‐Velten, W. N., Wolf, A., Huppke, B., Millan, F., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00932-7 · Cited by 97
Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities
Jung, B.-J., Yoo, H.-S., Shin, S., Park, Y., & Jeon, S. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.195 · Cited by 104
Radiation Resistance: A Matter of Transcription Factors
Galeaz, C., Totis, C., & Bisio, A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.662840 · Cited by 101
Nrf2 Modulation in Breast Cancer
Ghareghomi, S., Habibi-Rezaei, M., Arese, M., Saso, L., & Moosavi‐Movahedi, A. A. (2022) · Biomedicines · doi:10.3390/biomedicines10102668 · Cited by 97
Metabolic Plasticity of Tumor Cell Mitochondria
Cannino, G., Ciscato, F., Masgras, I., Sànchez‐Martìn, C., & Rasola, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00333 · Cited by 97
Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism
Smolková, K., Mikó, E., Kovàcs, T., Leguina‐Ruzzi, A., Sipos, A., & Bai, P. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8024 · Cited by 101
Auranofin/Vitamin C: A Novel Drug Combination Targeting Triple-Negative Breast Cancer
Hatem, E., Azzi, S., Banna, N. E., He, T., Heneman-Masurel, A., Vernis, L., Baïlle, D., Masson, V., Dingli, F., Loew, D., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy149 · Cited by 98
Mitochondria-Centric Review of Polyphenol Bioactivity in Cancer Models
Stevens, J. F., Revel, J. S., & Maier, C. S. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7404 · Cited by 93
The Role of Natural Products in Targeting Cardiovascular Diseases via Nrf2 Pathway: Novel Molecular Mechanisms and Therapeutic Approaches
Ooi, B. K., Chan, K., Goh, B. H., & Yap, W. H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01308 · Cited by 99
lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCFβ-TRCP-Mediated Degradation of NRF2 in Pancreatic Cancer
Yang, Q., Li, K., Huang, X., Zhao, C. N., Mei, Y., Li, X., Jiao, L., & Yang, H. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.11.035 · Cited by 93
Disrupting the ‘Warburg effect’ re-routes cancer cells to OXPHOS offering a vulnerability point via ‘ferroptosis’-induced cell death
Ždralević, M., Vučetić, M., Daher, B., Marchiq, I., Parks, S. K., & Pouysségur, J. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.12.002 · Cited by 93
Nrf2 Pathway in Age-Related Neurological Disorders: Insights into MicroRNAs
Paladino, S., Conte, A., Caggiano, R., Pierantoni, G. M., & Faraonio, R. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491465 · Cited by 92
Targeting IDH1-Mutated Malignancies with NRF2 Blockade
Liu, Y., Lu, Y., Celiku, O., Li, A., Wu, Q., Zhou, Y., & Yang, C. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy230 · Cited by 91
Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression
Ma-on, C., Sanpavat, A., Whongsiri, P., Suwannasin, S., Hirankarn, N., Tangkijvanich, P., & Boonla, C. (2017) · Medical Oncology · doi:10.1007/s12032-017-0914-5 · Cited by 93
Contradictory roles of Nrf2/Keap1 signaling pathway in cancer prevention/promotion and chemoresistance
Jeddi, F., Soozangar, N., Sadeghi, M. R., Somi, M. H., & Samadi, N. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.03.008 · Cited by 90
Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma
Fabrizio, F. P., Costantini, M., Copetti, M., la Torre, A., Sparaneo, A., Fontana, A., Poeta, M. L., Gallucci, M., Sentinelli, S., Graziano, P., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14492 · Cited by 92
Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model
Bose, C., Awasthi, S., Sharma, R., Beneš, H., Hauer‐Jensen, M., Boerma, M., & Singh, S. P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193918 · Cited by 88
“NRF2 addiction” in lung cancer cells and its impact on cancer therapy
Hammad, A., Namani, A., Elshaer, M., Wang, X. J., & Tang, X. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.09.016 · Cited by 87
Hormetic potential of methylglyoxal, a side-product of glycolysis, in switching tumours from growth to death
Nokin, M., Durieux, F., Bellier, J., Peulen, O., Uchida, K., Spiegel, D. A., Cochrane, J. R., Hutton, C. A., Castronovo, V., & Bellahcène, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-12119-7 · Cited by 88
Keap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer
Chen, F., Xiao, M., Hu, S., & Wang, M. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1381467 · Cited by 94
Loss-of-function mutations in KEAP1 drive lung cancer progression via KEAP1/NRF2 pathway activation
Gong, M., Li, Y., Ye, X., Zhang, L., Wang, Z., Xu, X., Shen, Y., & Zheng, C. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00568-z · Cited by 86
Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer
Chen, D., Guo, Z., Yao, L., Sun, Y., Dian, Y., Zhao, D., Ke, Y., Zeng, F., Zhang, C., Deng, G., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103686 · Cited by 95
The molecular activity of cannabidiol in the regulation of Nrf2 system interacting with NF-κB pathway under oxidative stress
Atalay, S., Gęgotek, A., & Skrzydlewska, E. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102489 · Cited by 90
Brusatol-Mediated Inhibition of c-Myc Increases HIF-1α Degradation and Causes Cell Death in Colorectal Cancer under Hypoxia
Oh, E., Kim, C. W., Kim, H. G., Lee, J., & Park, H. J. (2017) · Theranostics · doi:10.7150/thno.20861 · Cited by 83
Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy
Bono, S., Feligioni, M., & Corbo, M. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00479-8 · Cited by 86
Effects and Mechanisms of Kaempferol in the Management of Cancers through Modulation of Inflammation and Signal Transduction Pathways
Almatroudi, A., Allemailem, K. S., Alwanian, W. M., Alharbi, B. F., Alrumaihi, F., Khan, A. A., Almatroodi, S. A., & Rahmani, A. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108630 · Cited by 90
4-Hydroxynonenal metabolites and adducts in pre-carcinogenic conditions and cancer
Guéraud, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.025 · Cited by 86
New Insights into the Nrf-2/HO-1 Signaling Axis and Its Application in Pediatric Respiratory Diseases
Zhang, X., Ding, M., Zhu, P., Huang, H., Zhuang, Q., Shen, J., Cai, Y., Zhao, M., & He, Q. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3214196 · Cited by 84
Targeting Cancer Stem Cell Redox Metabolism to Enhance Therapy Responses
Luo, M., & Wicha, M. S. (2018) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2018.10.003 · Cited by 81
Post‐transcriptional regulation of Nrf2‐mRNA by the mRNA‐binding proteins HuR and AUF1
Poganik, J. R., Long, M. J. C., Disare, M. T., Liu, X., Chang, S., Hla, T., & Aye, Y. (2019) · The FASEB Journal · doi:10.1096/fj.201901930r · Cited by 79
The Regulatory Effect of Phytochemicals on Chronic Diseases by Targeting Nrf2-ARE Signaling Pathway
He, W., Lv, C., Chen, Z., Shi, M., Zeng, C., Hou, D., & Qin, S. (2023) · Antioxidants · doi:10.3390/antiox12020236 · Cited by 79

Authors: Menegon, S., Columbano, A., & Giordano, S.
Affiliations: Candiolo Cancer Institute (IT)
University of Cagliari (IT)
Corresponding author: Menegon, Silvia
Columbano, Amedeo
Giordano, Silvia
ORCID: Menegon, Silvia
Columbano, Amedeo
Giordano, Silvia
Venue: Trends in Molecular Medicine
Publisher: Elsevier BV
Published: 2016-07
Volume: 22
Issue: 7
Pages: 578-593
ISSN: 1471-4914 (ISSN-L)
DOI: 10.1016/j.molmed.2016.05.002
OpenAlex: W2417535489
Cited by: 633
References: 114
Citations by year: 2026: 28 · 2025: 43 · 2024: 64 · 2023: 60 · 2022: 74 · 2021: 75 · 2020: 69 · 2019: 72 · 2018: 73 · 2017: 57 · 2016: 16
FWCI: 6.58
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Trends in Molecular Medicine (publishedVersion)
PubMed (publishedVersion)
Institutional Research Information System University of Turin (University of Turin) (submittedVersion, cc-by-nc-nd)
UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
Funders: Associazione Italiana per la Ricerca sul Cancro (15464, 15279, IG-15279)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
Keywords: Nrf2, Nrf2 signaling, oncogenic function, tumor suppressor, oxidative stress, chemoresistance, radioresistance (biology), Nrf2 inhibitors, therapeutic target, cancer
MeSH terms: Kelch-Like ECH-Associated Protein 1, Animals, Antineoplastic Agents, Humans, Mutation, Neoplasms, Signal Transduction, Gene Expression Regulation, Neoplastic, Oxidative Stress, MicroRNAs, Epigenesis, Genetic, NF-E2-Related Factor 2, Drug Discovery, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Dual Roles of NRF2 in Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks